CASP3 and cancer: Both CEP-26939 and its closely related analog ALK inhibitor, CEP-28122, have been reported to lead to growth inhibition in a variety of cultivated human ALK-related cancer cell lines, including neuroblastoma, through caspase 3/7 activation and apoptosis [25], [45].